US: 1.646.568.9797 (24x5)
UK: 44.330.808.0580 (24x5)
Worldwide: 91.703.051.960 (24x7)
This report studies the global 10-Deacetylbaccatin III market status and forecast, categorizes the global 10-Deacetylbaccatin III market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa). This report studies the 10-Deacetylbaccatin III market. 10-Deacetylbaccatin III, also known as 10-DAB or 10-DAB III, is a closely related natural organic compounds isolated from dried needles and small branches of the European yew tree (Taxus baccata).10-Deacetylbaccatin III is a precursor to the anti-cancer drug docetaxel (Taxotere). pacitaxel (taxol); cabazitaxel. 10-10-deacetylbaccatin III was found to selectively inhibit the growth of L. DONOVANI intracellular amastigotes within J774 murine macrophages in vitro at nanomolar concentrations with an IC(50) value of 70 nM. As new companies enter the market for finished paclitaxel, bulk demand will increase as competition forces down prices, the study notes, adding that, with the drug becoming more affordable, physicians are expected to prescribe it more freely. However, while demand may be rising, paclitaxel is derived from a natural resource, and its long-term availability is in question. Yew trees are slow-growing, and the extraction process requires numerous trees to supply an adequate amount, it says. The possible scarcity of the product is spurring sales, especially to the research sector where large stocks are necessary for proper experimentation. However, the report notes that enterprising companies have found ways to circumvent this issue and increase supply. With advances in technology, new and better ways of extracting paclitaxel have evolved, with plant cell culture techniques and genetic engineering also emerging as fruitful methods of enhancing production says F&S. These methods have resulted in ample and continuous supplies, which is expected to boost the quantities of bulk paclitaxel, and subsequently augment the revenues generated by finished products, the report adds. The global 10-Deacetylbaccatin III market is valued at 58 million US$ in 2017 and will reach 78 million US$ by the end of 2025, growing at a CAGR of 3.9% during 2018-2025. The major manufacturers covered in this report SM Herbals Alchem International Indena South Pharmaceutical HAOXUAN Yuannan Hande Sai Phytoceuticals Sarv Biolabs Pvt Aphios Hainan Yew Pharmaceutical Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering North America Europe China Japan India Southeast Asia Other regions (Central & South America, Middle East & Africa) We can also provide the customized separate regional or country-level reports, for the following regions: North America United States Canada Mexico Asia-Pacific China India Japan South Korea Australia Indonesia Singapore Rest of Asia-Pacific Europe Germany France UK Italy Spain Russia Rest of Europe Central & South America Brazil Argentina Rest of South America Middle East & Africa Saudi Arabia Turkey Rest of Middle East & Africa On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into ?95% ?98.0% Others By Application, the market can be split into Production of Docetaxel Production of Paclitaxel Others The study objectives of this report are: To analyze and study the global 10-Deacetylbaccatin III capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025); Focuses on the key 10-Deacetylbaccatin III manufacturers, to study the capacity, production, value, market share and development plans in future. Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis. To define, describe and forecast the market by type, application and region. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks. To identify significant trends and factors driving or inhibiting the market growth. To analyze the opportunities in the market for stakeholders by identifying the high growth segments. To strategically analyze each submarket with respect to individual growth trend and their contribution to the market. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market. To strategically profile the key players and comprehensively analyze their growth strategies. In this study, the years considered to estimate the market size of 10-Deacetylbaccatin III are as follows: History Year: 2013-2017 Base Year: 2017 Estimated Year: 2018 Forecast Year 2018 to 2025 For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered. Key Stakeholders 10-Deacetylbaccatin III Manufacturers 10-Deacetylbaccatin III Distributors/Traders/Wholesalers 10-Deacetylbaccatin III Subcomponent Manufacturers Industry Association Downstream Vendors Available Customizations Regional and country-level analysis of the 10-Deacetylbaccatin III market, by end-use. Detailed analysis and profiles of additional market players.
Table of Contents Global 10-Deacetylbaccatin III Market Professional Survey Report 2018 1 Industry Overview of 10-Deacetylbaccatin III 1.1 Definition and Specifications of 10-Deacetylbaccatin III 1.1.1 Definition of 10-Deacetylbaccatin III 1.1.2 Specifications of 10-Deacetylbaccatin III 1.2 Classification of 10-Deacetylbaccatin III 1.2.1 ?95% 1.2.2 ?98.0% 1.2.3 Others 1.3 Applications of 10-Deacetylbaccatin III 1.3.1 Production of Docetaxel 1.3.2 Production of Paclitaxel 1.3.3 Others 1.4 Market Segment by Regions 1.4.1 North America 1.4.2 Europe 1.4.3 China 1.4.4 Japan 1.4.5 Southeast Asia 1.4.6 India 2 Manufacturing Cost Structure Analysis of 10-Deacetylbaccatin III 2.1 Raw Material and Suppliers 2.2 Manufacturing Cost Structure Analysis of 10-Deacetylbaccatin III 2.3 Manufacturing Process Analysis of 10-Deacetylbaccatin III 2.4 Industry Chain Structure of 10-Deacetylbaccatin III 3 Technical Data and Manufacturing Plants Analysis of 10-Deacetylbaccatin III 3.1 Capacity and Commercial Production Date of Global 10-Deacetylbaccatin III Major Manufacturers in 2017 3.2 Manufacturing Plants Distribution of Global 10-Deacetylbaccatin III Major Manufacturers in 2017 3.3 R&D Status and Technology Source of Global 10-Deacetylbaccatin III Major Manufacturers in 2017 3.4 Raw Materials Sources Analysis of Global 10-Deacetylbaccatin III Major Manufacturers in 2017 4 Global 10-Deacetylbaccatin III Overall Market Overview 4.1 2013-2018E Overall Market Analysis 4.2 Capacity Analysis 4.2.1 2013-2018E Global 10-Deacetylbaccatin III Capacity and Growth Rate Analysis 4.2.2 2017 10-Deacetylbaccatin III Capacity Analysis (Company Segment) 4.3 Sales Analysis 4.3.1 2013-2018E Global 10-Deacetylbaccatin III Sales and Growth Rate Analysis 4.3.2 2017 10-Deacetylbaccatin III Sales Analysis (Company Segment) 4.4 Sales Price Analysis 4.4.1 2013-2018E Global 10-Deacetylbaccatin III Sales Price 4.4.2 2017 10-Deacetylbaccatin III Sales Price Analysis (Company Segment) 5 10-Deacetylbaccatin III Regional Market Analysis 5.1 North America 10-Deacetylbaccatin III Market Analysis ... | read more...